Association of the smoothelin (SMTN) gene with cerebral infarction in men: A haplotype-based case-control study

Vascular Medicine (United Kingdom)

Volumn 17, Issue 5, 2012, Pages 317-325

  Jiang, Jie ^a,b   Nakayama, Tomohiro ^a   Shimodaira, Masanori ^a   Sato, Naoyuki ^a   Aoi, Noriko ^a   Sato, Mikano ^a   Izumi, Yoichi ^a   Kasamaki, Yuji ^a   Ohta, Masakatsu ^a   Soma, Masayoshi ^a   Matsumoto, Koichi ^a   Kawamura, Hiroshi ^a   Ozawa, Yukio ^a   Hinohara, Shigeaki ^c   Doba, Nobutaka ^c   Ma, Yitong ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c Life Planning Center   (Japan)

Author keywords

case control study; cerebral infarction; haplotype; single nucleotide polymorphism; SMTN

Indexed keywords

CYTOSKELETON PROTEIN; SMOOTHELIN;

ADULT; AGED; ARTICLE; BRAIN INFARCTION; CONTROLLED STUDY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; SMTN GENE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CEREBRAL INFARCTION; CYTOSKELETAL PROTEINS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MIDDLE AGED; MUSCLE PROTEINS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS;

EID: 84867384694     PISSN: 1358863X     EISSN: 14770377     Source Type: Journal    
DOI: 10.1177/1358863X12453938     Document Type: Article

References (36)

1. Kiyohara Y, Kubo M, Kato I, et al. Ten-year prognosis of stroke and risk factors for death in a Japanese community: The Hisayama study. Stroke. 2003 ; 34: 2343-2348
2. Dominiczak AF, Negrin DC, Clark JS, et al. Genes and hypertension from gene mapping in experimental models to vascular gene transfer strategies. Hypertension. 2000 ; 35: 164-172
3. Saposnik G, Terzaghi MA. Genetical aspects in cerebrovascular disease. Rev Neurol. 1999 ; 28: 1098-1104
4. Munger MA, Hawkins DW. Atherothrombosis: Epidemiology, pathophysiology, and prevention. J Am Pharm Assoc. 2004 ; 44: S5-12
5. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999 ; 340: 115-126
6. Rikitake Y, Liao JK. ROCKs as therapeutic targets in cardiovascular diseases. Expert Rev Cardiovasc Ther. 2005 ; 3: 441-451
7. Libby P. Inflammation in atherosclerosis. Nature. 2002 ; 420: 868-874
8. van Eys GJ, Völler MC, Timmer EJ, et al. Smoothelin expression characteristics: Development of a smooth muscle cell in vitro system and identification of a vascular variant. Cell Struct Funct. 1997 ; 22: 65-72
9. Wehrens XH, Mies B, Gimona M, et al. Localization of smoothelin in avian smooth muscle and identification of a vascular-specific isoform. FEBS Lett. 1997 ; 405: 315-320
10. Niessen P, Rensen S, van Deursen J, et al. Smoothelin-a is essential for functional intestinal smooth muscle contractility in mice. Gastroenterology. 2005 ; 129: 1592-1601
11. van der Loop FT, Gabbiani G, Kohnen G, et al. Differentiation of smooth muscle cells in human blood vessels as defined by smoothelin, a novel marker for the contractile phenotype. Arterioscler Thromb Vasc Biol. 1997 ; 17: 665-671
12. Rensen SS, Thijssen VL, De Vries CJ, et al. Expression of the smoothelin gene is mediated by alternative promoters. Cardiovasc Res. 2002 ; 55: 850-863
13. Tharp DL, Wamhoff BR, Turk JR, et al. Upregulation of intermediate-conductance Ca2+-activated K+ channel (IKCa1) mediates phenotypic modulation of coronary smooth muscle. Am J Physiol Heart Circ Physiol. 2006 ; 291: H2493 - H2503
14. Hao H, Gabbiani G, Camenzind E, et al. Phenotypic modulation of intima and media smooth muscle cells in fatal cases of coronary artery lesion. Arterioscler Thromb Vasc Biol. 2006 ; 26: 326-332
15. Hinohara S, Doba N. The future profile of health promotion and disease prevention in Japan: Based on the study of seniors over age 75. Methods Inf Med. 2005 ; 44: 342-347
16. Nakayama T, Soma M, Rehemudula D, et al. Association of 5′ upstream promoter region of prostacyclin synthase gene variant with cerebral infarction. Am J Hypertens. 2000 ; 13: 1263-1267
17. Kiyohara Y, Kato I, Iwamoto H, et al. The impact of alcohol and hypertension on stroke incidence in a general Japanese population. The Hisayama study. Stroke. 1995 ; 26: 368-372
18. Akishita M. Gender-specific medicine and angiology. J Jpn Coll Angiol. 2006 ; 46: 137-141
19. Olson JM, Wijsman EM. Design and sample-size considerations in the detection of linkage disequilibrium with a disease locus. Am J Hum Genet. 1994 ; 55: 574-580
20. Nakayama T, Soma M, Rahmutula D, et al. Isolation of the 5′-flanking region of genes by thermal asymmetric interlaced polymerase chain reaction. Med Sci Monit. 2001 ; 7: 345-349
21. Sano M, Kuroi N, Nakayama T, et al. Association study of calcitonin-receptor-like receptor gene in essential hypertension. Am J Hypertens. 2005 ; 18: 403-408
22. Livak KJ, Marmaro J, Todd JA. Towards fully automated genome-wide polymorphism screening. Nat Genet. 1995 ; 9: 341-342
23. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from in complete data via the EM algorithm. J R Stat Soc. 1977 ; 39: 1-22
24. Sato M, Nakayama T, Soma M, et al. Association between prostaglandin E2 receptor gene and essential hypertension. Prostaglandins Leukot Essent Fatty Acids. 2007 ; 77: 15-20
25. Haketa A, Soma M, Nakayama T, et al. Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J Hypertens. 2004 ; 22: 1903-1907
26. Morita A, Nakayama T, Soma M. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am J Hypertens. 2006 ; 19: 593-600
27. Seno H, Satoh K, Tsuji S, et al. Novel interleukin-4 and interleukin-1 receptor antagonist gene variations associated with non-cardia gastric cancer in Japan: Comprehensive analysis of 207 polymorphisms of 11 cytokine genes. J Gastroenterol Hepatol. 2007 ; 22: 729-737
28. Lewis CM. Genetic association studies: Design, analysis and interpretation. Brief Bioinform. 2002 ; 3: 146-153
29. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 ; 117: e25 - e146
30. Turtzo LC, McCullough LD. Sex differences in stroke. Cerebrovasc Dis. 2008 ; 26: 462-474
31. Du L, Bayir H, Lai Y, et al. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem. 2004 ; 279: 38,563-38,570
32. Hagberg H, Wilson MA, Matsushita H, et al. PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem. 2004 ; 90: 1068-1075
33. Yuan M, Siegel C, Zeng Z, et al. Sex differences in the response to activation of the poly (ADP-ribose) polymerase pathway after experimental stroke. Exp Neurol. 2009 ; 217: 210-218
34. van Eys GJ, Niessen PM, Rensen SS. Smoothelin in vascular smooth muscle cells. Trends Cardiovasc Med. 2007 ; 17: 26-30
35. Verhamme P, Quarck R, Hao H, et al. Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovasc Res. 2002 ; 56: 135-144
36. Vikman P, Edvinsson L. Gene expression profiling in the human middle cerebral artery after cerebral ischemia. Eur J Neurol. 2006 ; 13: 1324-1332